A Follow-up Study of Subjects With Type 1 Gaucher Disease Who Previously Received AVR-RD-02
Condition:   Type 1 Gaucher Disease Intervention:   Other: Safety and efficacy assessments Sponsor:   AvroBio Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials

A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy
Condition:   Gaucher Disease Intervention:   Drug: Velaglucerase alfa Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials